Accrelist Ltd
QZG
Company Profile
Business description
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.
Contact
10 Ubi Crescent, Ubi Techpark
Lobby E No. 03-95
Singapore408564
SGPT: +65 64466113
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 March 2027
Employees
671
Stocks News & Analysis
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,155.80 | 34.00 | 0.37% |
| CAC 40 | 8,259.60 | 13.81 | 0.17% |
| DAX 40 | 23,803.95 | 3.04 | -0.01% |
| Dow JONES (US) | 47,915.24 | 270.56 | -0.56% |
| FTSE 100 | 10,600.53 | 2.95 | -0.03% |
| HKSE | 25,893.54 | 141.14 | 0.55% |
| NASDAQ | 22,886.89 | 64.47 | 0.28% |
| Nikkei 225 | 56,924.11 | 1,028.79 | 1.84% |
| NZX 50 Index | 13,181.44 | 92.37 | -0.70% |
| S&P 500 | 6,818.24 | 6.42 | -0.09% |
| S&P/ASX 200 | 8,960.60 | 36.20 | 0.41% |
| SSE Composite Index | 3,986.22 | 20.05 | 0.51% |